Advertisement

The treatment of Malignant Melanoma by Fast Neutrons

  • Peter R. Blake
Part of the Cancer Treatment and Research book series (CTAR, volume 35)

Abstract

Malignant melanoma is posing an increasing problem in the temperate zones as the incidence is rising and the population presenting with the disease is becoming younger [1]. Conventional treatment has involved wide excision of the lesion with skin grafting which has produced high local control rates for small superficial tumors. However, it is not a satisfactory form of treatment for recurrent or deeply infiltrating tumors or for lesions in sites where wide excision would cause disfigurement or morbidity [2]. For tumors such as these and for widely disseminated disease, alternative forms of therapy have been sought for many years. Radiotherapy, chemotherapy, and immunotherapy have all been studied in clinical trials both alone and as adjuvants to surgery.

Keywords

Fast Neutron Field Size Linear Energy Transfer Complete Regression Wide Excision 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ellwood JM: The epidemiology of malignant melanoma. Hospital Update 11:503–514, 1985.Google Scholar
  2. 2.
    Ackerman AB, Scheiner AM: How wide and deep is wide and deep enough? Hum Pathol 14:743–744, 1983.PubMedCrossRefGoogle Scholar
  3. 3.
    Clark WH: In: The histogenesis and biologic behavior of primary human malignant melanomas of the skin, Bernardino EA, Mihm MC (eds). Cancer Res 29:705–726, 1969.Google Scholar
  4. 4.
    Breslow A: Thickness, cross-sectional area, and depth of invasion in prognosis of cutaneous melanoma. Ann Surg 172:902–908, 1970.PubMedCrossRefGoogle Scholar
  5. 5.
    Balch CM, Murad TM, Soong SJ: A multifactorial analysis of melanoma prognostic histopathological features comparing Clark’s and Breslow’s staging methods. Ann Surg 118:732–742, 1978.CrossRefGoogle Scholar
  6. 6.
    Milton GW, Shaw HM, Farago GA, McCarthy WH: Tumour thickness and the site and time of first recurrence in cutaneous malignant melanoma (Stage I). Br J Surg 67:543–546, 1980.PubMedCrossRefGoogle Scholar
  7. 7.
    Aitken DR, Clausen K, Klein JP, James AG: The extent of primary melanoma excision. Ann Surg 198:634–641, 1983.PubMedCrossRefGoogle Scholar
  8. 8.
    Cassileth BR, Lusk EJ, Tenaglia AN: Patients’ perceptions of the cosmetic impact of melanoma resection. Plast Reconstr Surg 71:73–75, 1983.PubMedGoogle Scholar
  9. 9.
    Adair FE: The treatment of melanoma. Surg Gynaecol Obstet 62:406–409, 1936.Google Scholar
  10. 10.
    Tod MC: Radiologic treatment of malignant melanoma. Br J Radiol 19:223–229, 1946.PubMedCrossRefGoogle Scholar
  11. 11.
    Mastrangelo M: In: Cancer; principles and practice of oncology, De Vita VT, Hellman S, Rosenberg SA (eds). New York: Lippincott, 1982, p 1132.Google Scholar
  12. 12.
    Ellis F: The radiosensitivity of malignant melanoma. Br J Radiol 12:327–352, 1939.CrossRefGoogle Scholar
  13. 13.
    Hellriegel W: Radiotherapy of primary and metastatic melanoma. Ann NY Acad Sci 100:131–141, 1963.PubMedGoogle Scholar
  14. 14.
    Harwood AR, Cummings BJ: Radiotherapy for malignant melanoma; a re-appraisal. Cancer Treat Rev 8:271–282, 1981.PubMedCrossRefGoogle Scholar
  15. 15.
    Habermalz H J, Fischer JJ: Radiation therapy of malignant melanoma. Cancer 38:2258–2262, 1976.PubMedCrossRefGoogle Scholar
  16. 16.
    Hornsey: The relationship between total dose number of fractions and fraction size in the response of malignant melanoma in patients. Br J Radiol 51:905–909, 1978.PubMedCrossRefGoogle Scholar
  17. 17.
    Overgaard J: Radiation treatment of malignant melanoma. Int J Radiat Oncol Biol Phys 11:1837–1839, 1985.PubMedCrossRefGoogle Scholar
  18. 18.
    Khan MS, Ross WM: The management of malignant melanoma; a retrospective analysis of 182 patients. Clin Radiol 35:151–154, 1984.PubMedCrossRefGoogle Scholar
  19. 19.
    Rofstad EK, Brustad T: Radiosensitivity of the cells of an established human melanoma cell line and the parent melanoma xenograft. Int J Radiat Oncol Biol Phys 44:447–454, 1983.Google Scholar
  20. 20.
    Smith IE, Courtenay VD, Mills J, Peckham MJ: In vitro radiation response of cells from four human tumours propagated in immune-suppressed mice. Cancer Res 38:390–392, 1978.PubMedGoogle Scholar
  21. 21.
    Guichard M, Gosse C, Malaise EP: Survival curve of a human melanoma in nude mice. J Natl Cancer Inst 58:1665–1669, 1977.PubMedGoogle Scholar
  22. 22.
    Hall EJ: Radiobiology for the radiologist. Maryland: Harper and Row, 1978, p 98.Google Scholar
  23. 23.
    Hall EJ, Roizin-Towle L, Theus B, August LS: Radiobiological properties of neutrons used in radiotherapy. Radiology 117:173–178, 1975.PubMedGoogle Scholar
  24. 24.
    Hornsey S, Vatistas W, Bewley DK, Parnell CJ: The effect of fractionation on four day survival of mice after whole-body neutron irradiation. Br J Radiol 38:878–880, 1965.PubMedCrossRefGoogle Scholar
  25. 25.
    Read J: The effect of ionisations on the broad bean root; X. The dependance of the x-ray sensitivity on dissolved oxygen. Br J Radiol 25:89–99, 1952.PubMedCrossRefGoogle Scholar
  26. 26.
    Gray LH, Conger AD, Ebert M, Hornsey S, Scott OCA: The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 26:638–648, 1953.PubMedCrossRefGoogle Scholar
  27. 27.
    Thomlinson RH, Gray LH: The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 9:539–549, 1955.PubMedCrossRefGoogle Scholar
  28. 28.
    Berendsen GW, Koot CJ, van Kersen GR, Bewley DK, Field SB, Parnell CJ: Int J Radiat Biol 10:317, 1967.CrossRefGoogle Scholar
  29. 29.
    Guichard M, Dertinger H, Malaise EP: Radiosensitivity of four human tumour xenografts. Influence of hypoxic and cell-cell contact. Radiat Res 95:602–609, 1983.PubMedCrossRefGoogle Scholar
  30. 30.
    van Putten LM, Kallman RF: Oxygenation status of a transplantable tumour during fractionated radiotherapy. J Natl Cancer Inst 40:441–451, 1968.PubMedGoogle Scholar
  31. 31.
    Stone RS: Clinical experience with fast neutron therapy. Am J Roentgenol 59:771–781, 1948.Google Scholar
  32. 32.
    Sheline GE, Philips TL, Field SB, Brennan TJ: Effects of fast neutrons on skin. Am J Roentgenol Radiother Nucl Med 111:31–41, 1971.Google Scholar
  33. 33.
    Fowler JF, Stern BE: Dose-time relationships in radiotherapy and the validity of cell survival curve models. Br J Radiol 36:163–173, 1963.PubMedCrossRefGoogle Scholar
  34. 34.
    Field SB: The relative biological effectiveness of fast neutrons for mammalian tissues. Radiology 93:915–920, 1969.PubMedGoogle Scholar
  35. 35.
    Catterall M, Bewley DK: Fast neutrons in the treatment of cancer, London: Academic Press, 1979.Google Scholar
  36. 36.
    Laramore GE, Krall JM, Thomas FJ, Griffin TW, Maor MH, Hendrickson FR: Fast neutron therapy for locally advanced prostate cancer: Results of an RTOG randomised study. Int J Radiat Oncol Biol Phys 11:1621–1627, 1985.PubMedCrossRefGoogle Scholar
  37. 37.
    Griffin TW, Davis R, Laramore GE, Maor MH, Hendrickson FR, Rodriguez-Antunez A, Davis L: Mixed beam radiation therapy for unresectable squamous cell carcinomas of the head and neck: The results of a randomised RTOG study. Int J Radiat Oncol Biol Phys 10:2211–2216, 1984.PubMedCrossRefGoogle Scholar
  38. 38.
    Griffin TW, Davis R, Hendrickson FR, Maor MH, Laramore GE: Fast neutron therapy for unresectable squamous cell carcinoma of the head and neck: The results of a randomised RTOG study. Int J Radiat Oncol Biol Phys 10:2217–2222, 1984.PubMedCrossRefGoogle Scholar
  39. 39.
    Blake PR, Catterall M, Errington RD: Treatment of malignant melanoma by fast neutrons. Br J Surg 72:517–519, 1985.PubMedCrossRefGoogle Scholar
  40. 40.
    Bessell EM, Catterall M: The regression of tumours of the head and neck treated with neutrons. Int J Radiat Oncol Biol Phys 9:799–807, 1983.PubMedCrossRefGoogle Scholar
  41. 41.
    Duncan W, Arnott S J, Orr JA, Kerr GA: The Edinburgh experience of fast neutron therapy. Int J Radiat Oncol Biol Phys 8:2155–2157, 1982.PubMedCrossRefGoogle Scholar
  42. 42.
    Catterall M: Results of neutron therapy. Differences, correlations and improvements. Int J Radiat Oncol Biol Phys 8:2141–2144, 1982.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishers, Boston 1987

Authors and Affiliations

  • Peter R. Blake

There are no affiliations available

Personalised recommendations